Ferring Pharmaceuticals
Ferring Pharmaceuticals
Explore linked clinical trials.18 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer | Intermediate Risk Non-Muscle Invasive Bladder Cancer | Recruiting | Phase 3 | 2026-10-07 | NCT06510374 | |
| Prospective, Multi-centre, Non-Interventional Study to Investigate the Effectiveness of REKOVELLE® for Ovarian Stimulation for Asian Women in Real World Settings | Genital Diseases, Urogenital Diseases, infertility disorder | Active, not recruiting | Not stated | 2026-09-30 | NCT06561958 | |
| To Investigate REKOVELLE in Chinese Women Undergoing Assisted Reproductive Technologies: Effectiveness, Safety, and Patterns of Use in Real-world Practice | Genital Diseases, Urogenital Diseases, infertility disorder | Active, not recruiting | Not stated | 2026-09-25 | NCT07029451 | |
| A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer | Non-muscle Invasive Bladder Cancer With Carcinoma in Situ | Recruiting | Phase 3 | 2026-09-25 | NCT06545955 | |
| Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Not yet recruiting | Phase 2 | 2026-09-17 | NCT07332351 | |
| Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis | Low-grade Upper Tract Urothelial Carcinoma | Recruiting | Phase 1 / Phase 2 | 2026-09-15 | NCT06668493 | |
| Ovulation Trigger Strategies in Low Ovarian Reserve (TRIGGERBEST) | Low Ovarian Reserve; Poor Ovarian Response | Recruiting | Phase 3 | 2026-09-11 | NCT07816562 | |
| Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy | Bowel Preparation | Recruiting | Phase 1 / Phase 2 | 2026-09-04 | NCT04113382 | |
| Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With High-grade, BCG Unresponsive, Non-muscle Invasive Bladder Cancer (NMIBC) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Active, not recruiting | Phase 3 | 2026-09-02 | NCT05704244 | |
| Embryo QUAlity in Ovarian Stimulation With hMG. | Genital Diseases, Urogenital Diseases, infertility disorder | Not yet recruiting | Phase 4 | 2026-07-08 | NCT07691073 | |
| PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Fetal Diseases, Hemic and Lymphatic Diseases, Hemorrhage, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, Obstetric Labor Complications, Obstetric Labor, Premature, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postpartum Hemorrhage, Urogenital Diseases, Uterine Hemorrhage, cardiovascular disorder, diabetes mellitus, endocrine system disorder, fetal growth restriction, follicular lymphoma, gestational diabetes, glucose metabolism disease, hereditary endocrine growth disease, hypertension, pregnancy-induced, hypertensive disorder, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, metabolic disease, neoplasm, placenta disorder, placental abruption, preeclampsia, pregnancy disorder, puerperal disorder, vascular disorder | Recruiting | Not stated | 2026-04-13 | NCT07263490 | |
| Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauterine Successful Experience (RISE) | Genital Diseases, Urogenital Diseases, infertility disorder | Recruiting | Phase 2 | 2026-04-08 | NCT07153367 | |
| Aurora Test for ART Donor Patients (AURORA-Donor) | Genital Diseases, Urogenital Diseases, infertility disorder | Recruiting | Not stated | 2025-08-11 | NCT06280677 | |
| Menopur And Rekovelle Combination Study Version 2.0 | infertility disorder, paroxysmal familial ventricular fibrillation | Recruiting | Phase 2 | 2025-07-31 | NCT06997900 | |
| Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients | Genital Diseases, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, malignant tumor of nasopharynx, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease, prostate cancer, prostate disorder | Recruiting | Not stated | 2025-06-11 | NCT04340024 | |
| Fit-for-Fertility Multicenter Randomized Controlled Trial | Body Weight, Body Weight Changes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Weight Loss, female infertility, female reproductive system disorder, infertility disorder, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Not applicable | 2025-03-19 | NCT03908099 | |
| Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy | prostate adenocarcinoma | Active, not recruiting | Phase 2 | 2024-12-16 | NCT01994239 | |
| Efficacy and Safety of Budesonide MMX® vs. Budesonide CR for Induction of Remission in Microscopic Colitis | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, intestinal disorder, microscopic colitis | Not yet recruiting | Phase 2 | 2023-12-04 | NCT05915104 |